Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity
This article is from
The Cancer Letter
archive.
Vol. 34 No. 10 | October 28, 2011
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
St. Jude Offers Three Fellowships
May 3, 1985
TCL Archive
NCI CTEP-Approved Trials For the Month of February
February 28, 2014
TCL Archive
Drugs and Targets: FDA approves Velcade in mantle cell lymphoma
October 17, 2014
TCL Archive
DCPC Board Okays Recompetition Of Computer Contract
May 30, 1986
TCL Archive
AACR 2014 Cancer Progress Report: More Federal Funds Needed
September 19, 2014
TCL Archive
NCI-Approved Group, Center Clinical Trials Listed
May 25, 2007